You are here

Pharmaceutical Approval Update May 2010

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Drugs discussed include carglumic acid tablets (Carbaglu) for children and adults with excessive ammonia levels; adapalene topical 0.1% lotion (Differin) for patients with acne vulgaris; and velaglucerase alfa for injection (VPRIV), an enzyme replacement therapy for pediatric and adult patients with type-1 Gaucher disease.